Andrew Witty, president of GlaxoSmithKline PLC's European pharmaceuticals division, will succeed Jean-Pierre Garnier as chief executive officer in May, the company announced yesterday.
Witty, 43, who was picked over two other internal candidates, joined the company in 1985 and has held his current job since 2003.
"Andrew's appointment follows a rigorous selection process by the board of directors," board chairman Sir Christopher Gent said.
The two other frontrunners for the job were Chris Viehbacher, head of Glaxo's US business, and David Stout, the pharmaceuticals division chief, according to people close to the company.
Witty's win may now lead to their departure, analysts said.
"Glaxo might lose both. I would be very surprised if Stout didn't move on. The best way of keeping Viehbacher may be to let Stout go and then promote Viehbacher," said Paul Diggle of Nomura Code Securities.
Witty has extensive experience working in many parts of the world, including developed and developing markets, as well as the US and Europe.
Garnier had originally been due to step down this month, when he turns 60, but the board last year extended his contract until May, so that he could oversee the rollout of key new products.
Garnier took charge of the company following the merger of Glaxo Wellcome and SmithKline Beecham that created it in 2000.
Witty takes over the world's second-largest drugmaker, behind US-based Pfizer Inc, at a testing time.
Glaxo boasts one of the largest pipelines of experimental drugs in the industry but many of its current blockbusters are losing patent protection and the group has been hit hard this year by safety concerns over diabetes pill Avandia.
With the shares falling 12 percent in the past five months, Glaxo has faced growing calls to improve investor returns. The company decided in July to nearly triple the share buyback program to ?12 billion (US$24.4 billion) -- yet some investors want more radical action, such as the divestment of the lucrative consumer health business.
Garnier's departure marks a further changing of the guard with the top management ranks of Europe's drug industry.
Last year, David Brennan replaced Tom McKillop as CEO of AstraZeneca Plc, Glaxo's smaller British rival.
In continental Europe, Gerard Le Fur took over from Jean-Francois Dehecq as CEO of France's Sanofi-Aventis SA in January and next March Severin Schwan will replace Franz Humer as CEO of Swiss-based Roche Holding AG.
The move will leave Novartis AG's Daniel Vasella as the longest-serving CEO at a the head of a major European drugmaker by the middle of next year. Vasella said last month he did not plan to step down any time soon.
NO HUMAN ERROR: After the incident, the Coast Guard Administration said it would obtain uncrewed aerial vehicles and vessels to boost its detection capacity Authorities would improve border control to prevent unlawful entry into Taiwan’s waters and safeguard national security, the Mainland Affairs Council (MAC) said yesterday after a Chinese man reached the nation’s coast on an inflatable boat, saying he “defected to freedom.” The man was found on a rubber boat when he was about to set foot on Taiwan at the estuary of Houkeng River (後坑溪) near Taiping Borough (太平) in New Taipei City’s Linkou District (林口), authorities said. The Coast Guard Administration’s (CGA) northern branch said it received a report at 6:30am yesterday morning from the New Taipei City Fire Department about a
IN BEIJING’S FAVOR: A China Coast Guard spokesperson said that the Chinese maritime police would continue to carry out law enforcement activities in waters it claims The Philippines withdrew its coast guard vessel from a South China Sea shoal that has recently been at the center of tensions with Beijing. BRP Teresa Magbanua “was compelled to return to port” from Sabina Shoal (Xianbin Shoal, 仙濱暗沙) due to bad weather, depleted supplies and the need to evacuate personnel requiring medical care, the Philippine Coast Guard (PCG) spokesman Jay Tarriela said yesterday in a post on X. The Philippine vessel “will be in tiptop shape to resume her mission” after it has been resupplied and repaired, Philippine Executive Secretary Lucas Bersamin, who heads the nation’s maritime council, said
REGIONAL STABILITY: Taipei thanked the Biden administration for authorizing its 16th sale of military goods and services to uphold Taiwan’s defense and safety The US Department of State has approved the sale of US$228 million of military goods and services to Taiwan, the US Department of Defense said on Monday. The state department “made a determination approving a possible Foreign Military Sale” to the Taipei Economic and Cultural Representative Office in the US for “return, repair and reshipment of spare parts and related equipment,” the defense department’s Defense Security Cooperation Agency said in a news release. Taiwan had requested the purchase of items and services which include the “return, repair and reshipment of classified and unclassified spare parts for aircraft and related equipment; US Government
More than 500 people on Saturday marched in New York in support of Taiwan’s entry to the UN, significantly more people than previous years. The march, coinciding with the ongoing 79th session of the UN General Assembly, comes close on the heels of growing international discourse regarding the meaning of UN Resolution 2758. Resolution 2758, adopted by the UN General Assembly in 1971, recognizes the People’s Republic of China (PRC) as the “only lawful representative of China.” It resulted in the Republic of China (ROC) losing its seat at the UN to the PRC. Taiwan has since been excluded from